SU854274A3 - Способ получени фракции гва ковойСМОлы - Google Patents

Способ получени фракции гва ковойСМОлы Download PDF

Info

Publication number
SU854274A3
SU854274A3 SU782600100A SU2600100A SU854274A3 SU 854274 A3 SU854274 A3 SU 854274A3 SU 782600100 A SU782600100 A SU 782600100A SU 2600100 A SU2600100 A SU 2600100A SU 854274 A3 SU854274 A3 SU 854274A3
Authority
SU
USSR - Soviet Union
Prior art keywords
ratio
acetone
mixture
guajacum
producing
Prior art date
Application number
SU782600100A
Other languages
English (en)
Inventor
Гютляйн Вернер
Вилингер Ханс
Риттерсдорф Вальтер
Вернер ВОЛЬФГАНГ
Original Assignee
Берингер Маннхайм Гмбх (Фир-Ma)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Маннхайм Гмбх (Фир-Ma) filed Critical Берингер Маннхайм Гмбх (Фир-Ma)
Application granted granted Critical
Publication of SU854274A3 publication Critical patent/SU854274A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/725Haemoglobin using peroxidative activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2326/00Chromogens for determinations of oxidoreductase enzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/904Oxidation - reduction indicators

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ ФРАКЦИИ ГВАЯКОВОЙ СМОЛЫ
Изобретение относитс  к области органической химии, а именно к способу получени  фракции гва ковой смо лы, примен емой в медицине в случае заболеваний органов пищеварени , при вод щих к по влению скрытой крови в стуле, обнаружение которой  вл етс  важным моментом при установлении пра вильного диагноза. Известна гва кова  смола, котора  добываетс  из сердцевины тропического дерева Guajacum officinal is и. sanktum и примен етс  дл  определени  скрытой крови в кале. Однако частое использование гва ковой смолы приводит к получению ошибочных результатов. Анализ осуществ л ют путем обработки взвеси кала перекисью водорода и спиртовым раствором гва ковой смолы. По вление гол бого окрашивани  указывает на наличие скрытой крови. За по вление голу бого окрашивани  ответственно два основных компонента смолы, а именно фурогва цин, а также гва конова  кислота 1. Однако гва кова  смола не всегда содержит имеющиес  в ней компоненты в одном и том же соотношении , часто образуютс  нестабильные компоненты, которые могут разлагатьс  и, таким образом, снижать точность и воспроизводимость анали- за. В то же врем  выделение и применение двух главных компонентов в индивидуальном виде затруднено, поскольку применение фурогва цина не дает стабильных результатов,о в выделение гва коновой кислоты возможно осуществить только с помощью тонкослойной хроматографии с очень низким выходом.. Цель изобретени  заключаетс  в разработке способа получени  новой стабильной смеси компонентов гва ковой смолы - фракции гва ковой смолы, пригодной дл  диагностики наличи  крови в кале. Поставленна  иель достигаетс  способом получени  фракции гва ковой смолы, заключающимс  в том, что гва ковую смолу, выделенную из сердцевины тропического дерева Guajacum offtcinalls и Guajacum sanktum раствор ют в ацетоне, затем прибавл ют толуол, после чего полученную смесь фильтруют, фильтрат упаривают досуха и остаток раствор ют в смеси н-гептана и уксусного эфира в соотнойюнии 2:5 или в ацетоне и разде

Claims (1)

  1. Формула изобретения
    Способ получения фракции гваяковой смолы, отличающийся тем, что гваяковую смолу, выделенную 4Q из сердцевины тропического дерева Guajacum officinalis и Guajacum sanktum растворяют в ацетоне, затем прибавляют толуол, после чего полученную смесь фильтруют, фильтрат упаривают досуха и остаток растворяют в сМеси н-гептана и уксусно· го эфира в соотношении 2:5 или в ацетоне и разделяют на колонке с силикагелем в атмосфере углекислого газа при помощи элюента, в качестве которого используют смесь н-гептана и уксусного эфира в соотношении 2:5 или смесь ацетона и толуола в соотношении 1:5, при этом отбирают фракции с Rf 0,45 в смеси толуол, диоксан и ледяная уксусная кислота в соотношении 90:25:10, упаривают их досуха и полученный остаток перекристаллизовывают из п-ксилола.
SU782600100A 1977-04-09 1978-04-07 Способ получени фракции гва ковойСМОлы SU854274A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2716061A DE2716061C2 (de) 1977-04-09 1977-04-09 Guajaconsäure A, Verfahren zu ihrer Herstellung und die Verwendung dieser Substanz als diagnostische Mittel

Publications (1)

Publication Number Publication Date
SU854274A3 true SU854274A3 (ru) 1981-08-07

Family

ID=6006094

Family Applications (1)

Application Number Title Priority Date Filing Date
SU782600100A SU854274A3 (ru) 1977-04-09 1978-04-07 Способ получени фракции гва ковойСМОлы

Country Status (18)

Country Link
US (2) US4219336A (ru)
JP (1) JPS588400B2 (ru)
AR (1) AR216788A1 (ru)
AT (1) AT358743B (ru)
BE (1) BE865700A (ru)
BR (1) BR7802179A (ru)
CA (1) CA1115724A (ru)
CH (1) CH636625A5 (ru)
DD (1) DD135768A5 (ru)
DE (1) DE2716061C2 (ru)
FI (1) FI781014A (ru)
FR (1) FR2386556A1 (ru)
GB (1) GB1571362A (ru)
HU (1) HU180211B (ru)
IT (1) IT1095395B (ru)
NL (1) NL7803721A (ru)
SE (1) SE7803890L (ru)
SU (1) SU854274A3 (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56117798A (en) * 1980-02-21 1981-09-16 Toyo Jozo Co Ltd Kit for measuring lipoid peroxide
US4526869A (en) * 1980-09-24 1985-07-02 Regents Of The University Of Minnesota Method for quantitatively determining the concentration of hemoglobin in a biological sample
US4956300A (en) * 1982-01-05 1990-09-11 Helena Laboratories Corporation Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
ZA829434B (en) * 1982-01-05 1984-05-30 Hematec Corp Home diagnostic aid and method for determining the presence of occult blood for use by the general public
ZA831268B (en) * 1982-04-30 1984-10-31 Hematec Corp Home diagnostic aid and method for determining the presence of occult blood for use by the general public
PH23572A (en) * 1982-05-28 1989-09-11 Smithkline Diagnostics Inc Specimen test slide for occult blood testing
US4541987A (en) * 1983-09-29 1985-09-17 Helena Laboratories Corporation Test pad for detecting occult blood
US4725553A (en) * 1983-09-29 1988-02-16 Helena Laboratories Corporation Test composition for detecting occult blood
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US5273888A (en) * 1984-01-16 1993-12-28 Helena Laboratories Corporation Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US4676950A (en) * 1984-02-03 1987-06-30 Foster Research Corporation Indicator and test device for detecting occult blood
US4615982A (en) * 1984-12-11 1986-10-07 Lawrence Paul J Fecal occult blood test
US4818702A (en) * 1986-06-02 1989-04-04 Litmus Concepts, Inc. Fecal occult blood test reagent
US5219554A (en) * 1986-07-03 1993-06-15 Advanced Magnetics, Inc. Hydrated biodegradable superparamagnetic metal oxides
JPS63223096A (ja) * 1987-03-11 1988-09-16 大日本印刷株式会社 精製グアヤク脂ならびにその製造方法
JP2589079B2 (ja) * 1987-03-11 1997-03-12 大日本印刷株式会社 精製グアャク脂の製造方法
US5081040A (en) * 1987-06-29 1992-01-14 Helena Laboratories Corporation Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
JP2660558B2 (ja) * 1988-08-17 1997-10-08 大日本印刷株式会社 精製グアヤク脂およびその製造法
US5182191A (en) * 1988-10-14 1993-01-26 Pacific Biotech, Inc. Occult blood sampling device and assay
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5629340A (en) * 1993-01-11 1997-05-13 Tsumura & Co. Angiogenesis inhibitor and novel compound
US5447868A (en) 1993-09-14 1995-09-05 Propper Manufacturing Co. Inc. Method, reagent and kit for the detection of fecal occult blood
US6309887B1 (en) * 1998-01-27 2001-10-30 Flexsite Diagnostics, Inc. Filter paper treatment for improved diagnostic assays
US7109038B2 (en) * 2002-06-13 2006-09-19 The Johns Hopkins University Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications
US7195878B2 (en) * 2004-09-30 2007-03-27 Cryo-Genomics Device and method for fecal testing
US9091682B1 (en) 2014-05-01 2015-07-28 Steven M Hacker Tissue specimen bottle with color indicator in lid verifying and confirming presence of human tissue or blood contained in specimen bottle
US11597961B2 (en) 2019-04-22 2023-03-07 Qualitic Biotechnology LLC Rapid colorimetric diagnostic test for C. difficile

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2258673A (en) * 1940-02-07 1941-10-14 Nat Oil Prod Co Process for treating fat-soluble vitamin-containing materials
US2345098A (en) * 1941-07-26 1944-03-28 Nat Oil Prod Co Process of saponifying vitamin-containing fatty material
US2529446A (en) * 1948-07-02 1950-11-07 Swift & Co Gum guaiac treatment
DK153334C (da) * 1974-01-09 1988-11-14 Shionogi & Co Diagnostiske praeparater
JPS5263794A (en) * 1975-11-21 1977-05-26 Shionogi Seiyaku Kk Test piece for latent blood
FI52256C (fi) * 1975-12-08 1977-07-11 Osmo Antero Suovaniemi Laite näytteiden ottamista varten näytteiden kuljettamiseksi ja analys oimiseksi.

Also Published As

Publication number Publication date
FR2386556A1 (fr) 1978-11-03
BR7802179A (pt) 1978-12-19
JPS588400B2 (ja) 1983-02-15
JPS53127812A (en) 1978-11-08
AT358743B (de) 1980-09-25
FR2386556B1 (ru) 1982-11-05
NL7803721A (nl) 1978-10-11
IT7822063A0 (it) 1978-04-06
ATA248678A (de) 1980-02-15
SE7803890L (sv) 1978-10-10
AR216788A1 (es) 1980-01-31
US4297271A (en) 1981-10-27
BE865700A (fr) 1978-10-05
HU180211B (en) 1983-02-28
FI781014A (fi) 1978-10-10
GB1571362A (en) 1980-07-16
CA1115724A (en) 1982-01-05
IT1095395B (it) 1985-08-10
DD135768A5 (de) 1979-05-23
DE2716061C2 (de) 1982-03-25
US4219336A (en) 1980-08-26
DE2716061A1 (de) 1978-10-19
CH636625A5 (de) 1983-06-15

Similar Documents

Publication Publication Date Title
SU854274A3 (ru) Способ получени фракции гва ковойСМОлы
Nelson et al. A method for the determination of 17-hydroxycorticosteroids in blood: 17-hydroxycorticosterone in the peripheral circulation
Horio et al. Preparation of crystalline Pseudomonas cytochrome c-551 and its general properties
Banks et al. Chemistry of the Coccoidea. II. Condensed polycyclic pigments from two Australian pseudococcids (Hemiptera)
Seneviratne et al. The amino acids of the genus Acacia
DE2920292A1 (de) L- gamma -glutamyl-3-carboxy-4-hydroxyanilid und dessen salze, verfahren zu dessen herstellung und dessen verwendung zur bestimmung der aktivitaet von gamma -glutamyltranspeptidase
EP0157384A2 (de) Substrate für Hydrolasen, Verfahren zu ihrer Herstellung und ihre Verwendung
Karoum et al. Further observations on the gas-chromatographic measurement of urinary phenolic and indolic metabolites
Galbraith et al. Insect moulting hormones: crustecdysone in Calliphora
Gardner et al. The polyoxyphenols of western red cedar (Thuja plicata Donn.): I. Isolation and preliminary characterization of plicatic acid
Al-said et al. Alkaloids of Erythroxylum macrocarpum and E. sideroxyloides
FR2404638A1 (fr) Procede de preparation d'acide pseudomonique
ELY et al. Studies of adrenal corticosteroids. I. Estimation of plasma corticosterone and cortisol
Whitlock et al. Structure and Synthesis of Lathyrine1
KOOLMAN et al. Enzymatic and chemical synthesis of 3-dehydroecdysterone, a metabolite of the moulting hormone of insects
SMITH et al. 24‐Hydroxycholesterol levels in human brain 1
Rothblat et al. A quantitative colorimetric assay for squalene
Wootton Studies in the bile acids. 1. A method of separation and identification
Vever-Bizet et al. The purification of haematoporphyrin IX and its acetylated derivatives
Kulonen et al. Experiences with paper chromatography in the study of α-keto acids
Joslyn et al. Leucoanthocyanins and related phenolic compounds of carob pods (Ceratonia siliqua)
DE2759962C2 (de) Verfahren zur quantitativen Bestimmung von Harnstoff
Baldwin et al. The Pigmentation of Cavernicolous Animals: I. The Pigments of some Isopod Crustacea
Parker The cryptoporphyrin of heart muscle
DE4021063A1 (de) Neue ss-galactosidase-substrate fuer den cedia